Safety and feasibility of autologous olfactory ensheathing cell and bone marrow mesenchymal stem cell co-transplantation in chronic human spinal cord injury: a clinical trial
  • 1.

    Mehrabi S, Eftekhari S, Moradi F, Delaviz H, Pourheidar B, Azizi M, et al. Cell therapy in spinal cord injury: a mini-reivew. Basic Clin Neurosci. 2013;4:172–6.

    PubMed  PubMed Central  Google Scholar 

  • 2.

    Anna Z, Katarzyna J-W, Joanna C, Barczewska M, Joanna W, Wojciech M. Therapeutic potential of olfactory ensheathing cells and mesenchymal stem cells in spinal cord injuries. Stem Cells Int. 2017;2017:3978595.

  • 3.

    Chou R-H, Lu C-Y, Wei-Lee, Fan J-R, Yu Y-L, Shyu W-C. The potential therapeutic applications of olfactory ensheathing cells in regenerative medicine. Cell Transplant. 2014;23:567–71.

    Article  Google Scholar 

  • 4.

    Lankford KL, Sasaki M, Radtke C, Kocsis JD. Olfactory ensheathing cells exhibit unique migratory, phagocytic, and myelinating properties in the X‐irradiated spinal cord not shared by Schwann cells. Glia. 2008;56:1664–78.

    Article  Google Scholar 

  • 5.

    Gilmour AD, Reshamwala R, Wright AA, Ekberg JA, St John JA. Optimizing olfactory ensheathing cell transplantation for spinal cord injury repair. J Neurotrauma. 2020;37:817–29.

    Article  Google Scholar 

  • 6.

    Taran R, Mamidi MK, Singh G, Dutta S, Parhar IS, John JP, et al. In vitro and in vivo neurogenic potential of mesenchymal stem cells isolated from different sources. J Biosci. 2014;39:157–69.

    CAS  Article  Google Scholar 

  • 7.

    Tabakow P, Jarmundowicz W, Czapiga B, Fortuna W, Miedzybrodzki R, Czyz M, et al. Transplantation of autologous olfactory ensheathing cells in complete human spinal cord injury. Cell Transplant. 2013;22:1591–612.

    Article  Google Scholar 

  • 8.

    Mendonça MVP, Larocca TF, de Freitas Souza BS, Villarreal CF, Silva LFM, Matos AC, et al. Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injury. Stem Cell Res Ther. 2014;5:126.

    Article  Google Scholar 

  • 9.

    Griffin JM, Bradke F. Therapeutic repair for spinal cord injury: combinatory approaches to address a multifaceted problem. EMBO Mol Med. 2020;12:e11505.

    CAS  Article  Google Scholar 

  • 10.

    Zhang J, Chen H, Duan Z, Chen K, Liu Z, Zhang L, et al. The effects of co-transplantation of olfactory ensheathing cells and schwann cells on local inflammation environment in the contused spinal cord of rats. Mol Neurobiol. 2017;54:943–53.

    CAS  Article  Google Scholar 

  • 11.

    Oraee-Yazdani S, Hafizi M, Zali A-R, Atashi A, Ashrafi F, Seddighi A-S, et al. Safety and possible outcome assessment of autologous Schwann cell and bone marrow mesenchymal stromal cell co-transplantation for treatment of patients with chronic spinal cord injury. Cytotherapy. 2013;15:782–91.

    Article  Google Scholar 

  • 12.

    Chen L, Huang H, Xi H, Zhang F, Liu Y, Chen D, et al. A prospective randomized double-blind clinical trial using a combination of olfactory ensheathing cells and Schwann cells for the treatment of chronic complete spinal cord injuries. Cell Transplant. 2014;23 1_suppl:35–44.

    Article  Google Scholar 

  • 13.

    Khuu HM, Patel N, Carter CS, Murray PR, Read EJ. Sterility testing of cell therapy products: parallel comparison of automated methods with a CFR‐compliant method. Transfusion. 2006;46:2071–82.

    Article  Google Scholar 

  • 14.

    Oraee-Yazdani S, Hafizi M, Atashi A, Ashrafi F, Seddighi A, Hashemi S, et al. Co-transplantation of autologous bone marrow mesenchymal stem cells and Schwann cells through cerebral spinal fluid for the treatment of patients with chronic spinal cord injury: safety and possible outcome. Spinal Cord. 2016;54:102–9.

    CAS  Article  Google Scholar 

  • 15.

    Hosseini SM, Sani M, Haider KH, Dorvash M, Ziaee SM, Karimi A, et al. Concomitant use of mesenchymal stem cells and neural stem cells for treatment of spinal cord injury: a combo cell therapy approach. Neurosci Lett. 2018;668:138–46.

    CAS  Article  Google Scholar 

  • 16.

    Cofano F, Boido M, Monticelli M, Zenga F, Ducati A, Vercelli A, et al. Mesenchymal stem cells for spinal cord injury: current options, limitations, and future of cell therapy. Int J Mol Sci. 2019;20:2698.

    CAS  Article  Google Scholar 

  • 17.

    Deng Y, Liu Y, Zhu W, Bi X, Wang Y, Ye M, et al. The co-transplantation of human bone marrow stromal cells and embryo olfactory ensheathing cells as a new approach to treat spinal cord injury in a rat model. Cytotherapy. 2008;10:551–64.

    CAS  Article  Google Scholar 

  • 18.

    Wu S, Cui G, Shao H, Du Z, Ng JC, Peng C. The cotransplantation of olfactory ensheathing cells with bone marrow mesenchymal stem cells exerts antiapoptotic effects in adult rats after spinal cord injury. Stem Cells Int. 2015;2015:516215.

  • 19.

    Gomes ED, Mendes SS, Assunção‐Silva RC, Teixeira FG, Pires AO, Anjo SI, et al. Co‐transplantation of adipose tissue‐derived stromal cells and olfactory ensheathing cells for spinal cord injury repair. Stem Cells. 2018;36:696–708.

    CAS  Article  Google Scholar 

  • 20.

    Reshamwala R, Shah M, John JS, Ekberg J. The link between olfactory ensheathing cell survival and spinal cord injury repair: a commentary on common limitations of contemporary research. Neural Regen Res. 2020;15:1848–9.

    Article  Google Scholar 

  • 21.

    Barnett SC, Chang L. Olfactory ensheathing cells and CNS repair: going solo or in need of a friend? Trends Neurosci. 2004;27:54–60.

    CAS  Article  Google Scholar 

  • 22.

    Paul C, Samdani AF, Betz RR, Fischer I, Neuhuber B. Grafting of human bone marrow stromal cells into spinal cord injury: a comparison of delivery methods. Spine. 2009;34:328–34.

    Article  Google Scholar 

  • 23.

    Satake K, Lou J, Lenke LG. Migration of mesenchymal stem cells through cerebrospinal fluid into injured spinal cord tissue. Spine. 2004;29:1971–9.

    Article  Google Scholar 

  • 24.

    Li L, Adnan H, Xu B, Wang J, Wang C, Li F, et al. Effects of transplantation of olfactory ensheathing cells in chronic spinal cord injury: a systematic review and meta-analysis. Eur Spine J. 2015;24:919–30.

    Article  Google Scholar 

  • 25.

    Macias MY, Syring MB, Pizzi MA, Crowe MJ, Alexanian AR, Kurpad SN. Pain with no gain: allodynia following neural stem cell transplantation in spinal cord injury. Exp Neurol. 2006;201:335–48.

    CAS  Article  Google Scholar 

  • 26.

    Lima C, Pratas-Vital J, Escada P, Hasse-Ferreira A, Capucho C, Peduzzi JD. Olfactory mucosa autografts in human spinal cord injury: a pilot clinical study. J Spinal Cord Med. 2006;29:191–203.

    Article  Google Scholar 

  • 27.

    Tuszynski M, Steeves J, Fawcett J, Lammertse D, Kalichman M, Rask C, et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion/exclusion criteria and ethics. Spinal Cord. 2007;45:222–31.

    CAS  Article  Google Scholar 

  • 28.

    Feron F, Perry C, Cochrane J, Licina P, Nowitzke A, Urquhart S, et al. Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain. 2005;128:2951–60.

    CAS  Article  Google Scholar 

  • 29.

    Lammertse D, Tuszynski M, Steeves J, Curt A, Fawcett J, Rask C, et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial design. Spinal Cord. 2007;45:232–42.

    CAS  Article  Google Scholar 

  • 30.

    Fawcett J, Curt A, Steeves J, Coleman W, Tuszynski M, Lammertse D, et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord. 2007;45:190–205.

    CAS  Article  Google Scholar 

  • Read original article here.